How do you decide if a fractional CRO is right for a Series A company when missed two quarters of quota?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

Buying Dynamics at Series A with Two Missed Quarters

The buying committee for a fractional CRO at a Series A company that has missed two quarters of quota is not the typical sales leadership hiring panel. It is a crisis committee: the CEO, the lead investor (likely the board seat from the Series A round), and often the head of product or the CTO if the company is technical. The CEO is panicked about board confidence and the next fundraising round; the investor is worried about the valuation markdown and their own carry; the product leader is frustrated that sales cannot sell what engineering built. The deal size at Series A typically ranges from $20k to $100k ACV, with a sales cycle of 45-90 days, but after two missed quarters, the average deal size may have shrunk as reps discount to close anything, and the cycle may have stretched to 120 days as prospects sense desperation.

Budget approval for a fractional CRO is not a line item in the annual operating plan – that plan is already broken. The budget comes from the board's discretionary reserve or from a reallocation of the VP of Sales salary that was never filled. The fractional CRO's fee, typically $15k-$30k per month plus a small success bonus, is approved by the CEO and one board member in a single call, not a formal committee. The buyer evaluates three things: (1) can this person diagnose the leak in 30 days without blowing up the existing team, (2) do they have direct experience selling to the same buyer persona and at the same price point, and (3) will they be willing to take a below-market cash comp in exchange for a liquidation preference or warrant on future revenue? The deal stalls on the second point – Series A companies often have a "proven" sales leader on paper who has sold enterprise software to $1M+ ACV accounts but cannot execute in the $30k ACV SMB motion that the company actually has. The investor will block a fractional hire who cannot demonstrate personal experience at the exact ACV range.

Sales-Cycle Implications of the Missed Quarters

The sales cycle at a Series A company that has missed two quarters is not a normal pipeline – it is a dead pipeline with a few zombies. The typical motion is founder-led outbound with a small inside sales team of 3-5 reps, but after two quarters of misses, the founder has stopped selling to focus on survival, the reps have lost confidence and are either coasting or actively interviewing, and the pipeline has a 60%+ gap between what is in the CRM and what is actually progressing. The ramp for any new leader – fractional or full-time – is compressed to 30 days, not the standard 90 days for a VP of Sales, because the company cannot afford another quarter of failure. The forecast behavior is delusional: the CEO will claim there are 10 deals at 80% probability in the current quarter, but upon inspection, those deals have no champion, no budget approval, and no next steps scheduled. The pipeline shape is a "reverse funnel" – there are more deals in the "closed lost" stage than in "proposal sent," and the top-of-funnel is generating 30% of the leads it did six months ago.

The leaks are specific to the Series A stage. First, the lead qualification criteria are nonexistent – reps are spending 80% of their time on inbound leads that are unqualified or from the wrong industry, because the ICP was never formally defined and the founder's early customers were all referrals. Second, the sales process has no defined stages or exit criteria; reps are moving deals to "negotiation" based on hope, not on a signed SOC 2 or a completed security questionnaire. Third, the pricing is inconsistent – some deals are quoted at $50k ACV, others at $15k, with no logic, because the company has been discounting reactively to buy revenue. Fourth, the post-sale handoff is broken – customers who do close are not onboarded properly, so churn is 8-10% per month, meaning the company is trying to fill a leaky bucket. A fractional CRO must identify these leaks in the first two weeks, not the first 90 days, or the company will not survive the third missed quarter.

What a Fractional CRO Looks Like in This Context

The fractional CRO for a Series A company with two missed quarters is not a strategic advisor who attends board meetings and offers gentle guidance. This person is a hands-on operator who will sit in the CRM daily, join sales calls, rewrite the pitch deck, and fire underperforming reps within the first 30 days. The first 90 days follow a specific cadence: Week 1-2 is a forensic audit of the CRM, the pipeline, the rep activity logs, and the customer churn data. Week 3-4 is a "reset" – the fractional CRO cuts the bottom 20% of reps, redefines the ICP with the product team, and implements a cold outbound cadence for the remaining reps. Month 2 is a "rebuild" – the fractional CRO personally carries a quota and closes 2-3 deals to demonstrate the motion works, while also hiring one or two new reps with specific experience in the target vertical. Month 3 is a "stabilize" – the fractional CRO sets a realistic forecast for the next quarter, implements a weekly pipeline review, and trains the CEO on how to sell without discounting.

The operating cadence is aggressive: daily standups with the sales team, weekly one-on-ones with each rep, bi-weekly pipeline reviews with the CEO and product lead, and monthly board updates. The fractional CRO owns the entire revenue function end-to-end: pipeline generation, deal execution, pricing, compensation, and hiring. They do not "advise" the CEO on strategy – they execute the strategy themselves, because the company cannot afford a month of analysis paralysis. The signals to convert to full-time are binary: (1) has the fractional CRO personally closed at least $200k in new ACV within 90 days, and (2) have they built a repeatable sales process that the existing team can execute without them? If both are yes, the company should offer a full-time role with a significant equity package and a 12-month cliff. If only the first is yes, the company needs to hire a full-time VP of Sales who can scale the process, and the fractional CRO can transition to a board advisor role. If neither is yes, the company has a product-market fit problem, not a sales leadership problem, and no amount of fractional or full-time CROs will fix it.

Why a Fractional CRO Fails Here Unless the Board Is Ready for Surgery

The most common mistake at Series A is hiring a fractional CRO as a "safe" alternative to a full-time hire, without giving them the authority to restructure the team and compensation. A fractional CRO who cannot fire the underperforming reps inherited from the founder will fail within 60 days, because the team will ignore their direction and the pipeline will not improve. The board must be prepared to accept a 30% reduction in headcount in the first month, which is painful for morale and for the founder who hired those reps personally. The fractional CRO must also have the authority to change the compensation plan immediately – moving from a high-base, low-commission structure to a variable-heavy plan that rewards pipeline generation and closed-won revenue, not activity. If the board is not willing to approve these changes within the first two weeks, the fractional CRO is a waste of money.

Another failure mode is the "fractional CRO as therapist" – the CEO hires a fractional leader to validate their own instincts and avoid making hard decisions. A Series A company that has missed two quarters needs a diagnostician who will tell the CEO that their product is not ready for the market, or that their pricing is too high, or that their target customer segment is wrong. A fractional CRO who is too diplomatic to deliver bad news will only extend the company's death spiral. The right fractional CRO will spend the first week interviewing customers who churned and prospects who lost, and will present a brutally honest report to the board in Week 2. If the board reacts defensively, the fractional CRO should resign immediately – the company is not ready for the truth.

The Financial Case for Fractional vs. Full-Time at Series A

The financial math at Series A is brutal: the company has 12-18 months of runway, and a full-time VP of Sales will cost $250k-$350k in cash plus 3-5% equity, with a 90-day ramp where they produce nothing. A fractional CRO costs $20k-$30k per month with no equity, and can start producing in 30 days. But the trade-off is that a fractional CRO has no long-term incentive to build a sustainable team – they are paid to fix the immediate crisis, not to build a $10M revenue engine. For a Series A company with two missed quarters, the question is whether the company can afford the 90-day dead period of a full-time hire. If the runway is less than 12 months, a fractional CRO is the only option, because the company cannot survive a quarter of zero pipeline progress. If the runway is 18+ months, a full-time hire is better, because the company needs a leader who will stay for 3-5 years and build a repeatable motion.

The fractional CRO should be paid on a hybrid model: a base monthly fee that covers 20 hours per week, plus a success bonus tied to specific milestones: $50k bonus for closing $500k in new ACV within 90 days, $25k bonus for reducing churn below 5% per month, and a 1% warrant pool for hitting the Q4 forecast. This aligns the fractional CRO with the company's survival, not just their monthly retainer. The board should also require the fractional CRO to invest their own time in recruiting a full-time successor – the fractional role is temporary by design, and the exit plan should be part of the engagement letter.

The Risk of a "Fractional CRO Loop" at Series A

A dangerous pattern at Series A is the "fractional CRO loop" – the company hires a fractional leader, they stabilize the pipeline for 3-6 months, then they leave, and the company hires another fractional leader because they cannot close a full-time hire. This happens when the board is unwilling to grant the equity and authority required for a full-time CRO, and the CEO is too burned out to manage a direct report. The result is a revolving door of fractional leaders who each reset the sales process, creating chaos for the team and the customers. A Series A company that has missed two quarters should break this loop by committing to a full-time hire within 90 days of the fractional CRO's start, with the fractional CRO acting as a bridge. If the company cannot find a full-time candidate within 90 days, the problem is not the candidate market – it is the company's reputation, compensation, or product. The fractional CRO should be empowered to tell the board that the company is not hireable in its current state, and the board must fix the underlying issues before any leader – fractional or full-time – can succeed.

FAQ

A question? How do I know if the missed quarters are a sales leadership problem or a product-market fit problem?

If the fractional CRO's forensic audit shows that the sales team is properly qualified, the pricing is consistent, the ICP is defined, and the pipeline is full but deals are still not closing, then the problem is product-market fit – the product does not solve a must-have problem for the target buyer. If the audit reveals that reps are spending 80% of their time on unqualified leads, the pricing is random, the ICP is undefined, and the pipeline is empty, then the problem is sales leadership and process. The fractional CRO should be able to determine this within 10 days.

A question? What if the CEO wants to keep the fractional CRO for 12 months instead of converting to full-time?

That is a red flag. A fractional CRO who stays for 12 months without converting to full-time is either failing to build a self-sustaining team or the CEO is avoiding the hard work of hiring a full-time leader. The maximum effective tenure for a fractional CRO at Series A is 6 months – beyond that, the team will not respect their authority and the board will lose confidence. If the CEO wants to extend beyond 6 months, the board should insist on a full-time hire search starting immediately.

A question? How do I set the fractional CRO's compensation to avoid misalignment?

Avoid a pure hourly rate or a fixed monthly retainer. Use a three-part model: a base monthly fee that covers 20 hours per week, a performance bonus tied to specific revenue milestones (e.g., $50k for $500k new ACV within 90 days), and a small equity component like a warrant pool that vests over 12 months. This ensures the fractional CRO is motivated to build a sustainable pipeline, not just collect a retainer. Also, include a clawback clause if the fractional CRO leaves before 90 days – this prevents them from taking the diagnostic work and leaving without executing.

A question? What if the fractional CRO wants to bring in their own team of contract SDRs or BDRs?

This is a common tactic from fractional CROs who have a "pod" of contractors they use across multiple clients. At Series A, this is almost always a bad idea – the contract SDRs will not be aligned to the company's specific ICP, they will not have the context to sell the product's nuances, and they will leave the moment the fractional CRO's engagement ends. The fractional CRO should be required to hire full-time SDRs who are employees of the company, or to use the existing team. If the fractional CRO insists on bringing their own team, it is a sign that they are treating your company as a short-term revenue source, not a long-term turnaround.

Sources